Strand Therapeutics
@StrandTx
Followers
2K
Following
197
Media
197
Statuses
419
Where synthetic biology meets mRNA therapeutics
Boston, MA
Joined October 2018
Excited our @StrandTx musician CMO @jasonlukemd is being awarded as a “Champion of @sitcancer" #SITC25 & playing trumpet in the Checkpoints band! Our team is excited to rock next gen #immunotherapy advances with multiple field leading, novel treatments for #cancer!
0
1
8
We’re honored to announce that Strand Therapeutics has been awarded the BioTech Startup of the Year award from BioTech Breakthrough! Thanks to the team at BioTech Breakthrough for highlighting the dedication of our team as we continue to forge a new path in mRNA therapeutics!
0
3
9
Check out the press release here! Congratulations Prashant and Ethan! https://t.co/Ys3xi5HMgb
businesswire.com
Strand Therapeutics promotes Prashant Nambiar to CSO and appoints Ethan Cash as SVP, Head of Portfolio Management and Program Development
0
0
1
We’re excited to announcethe promotion of Prashant Nambiar to Chief Scientific Officer and appointment of Ethan Cash to SVP of Program Development! As Strand’s research continues evolve towards clinical trials, these appointments will be vital in securing our success.
1
2
3
This week @StrandTx CMO @jasonlukemd is leading the @sitcancer 40th Annual Meeting! He will be voting on the Board of Directors, Lecturing on the future of TCR therapeutics & Chairing a session on late breaking clinical abstracts. More information here: https://t.co/ox1eNubHJs
0
1
8
Strand Therapeutics has always stood for more than scientific innovation—we stand for people, for families, and for communities. Our team participated in the Out of the Darkness Walk and raised $2,275 to support those impacted by suicide. Thanks to everyone who contributed!
0
0
2
We strive to make impacts on patient lives, and we’re just getting started! Looking forward to continuing to advance our programs and help patient across the global! #mRNA #patients #Biotech
🎙️@DrSynbio shares the story of @StrandTx's first clinical trial patient — and the moment he heard the initial results. On #Transcribed, he and @sajithw talk about betting early on mRNA, why medicine is the best investment, and what biotech needs to deliver breakthroughs faster.
0
1
4
Proud to share that @jasonlukemd will be joining Strand as Chief Medical Officer! Previously a professor @UPMC, he brings decades of expertise in cancer immunotherapies to the team.
3
2
17
Our mRNA genetic circuits turn cancer-fighting treatments on only inside tumors, improving precision and safety. Our goal is to drive greater precision and safety while bringing revolutionary outcomes for patients. Watch how it works ⬇️ #mRNA #CancerResearch #StrandTx
0
0
7
We just raised $153M Series B to advance the future of programmable mRNA medicines📷 Thank you to our investors fueling the next generation of cell-targeted genetic medicines. #biotech #mRNA #SeriesB #synbio #StrandTherapeutics
https://t.co/FTts6zYt0F
forbes.com
For years, Jake Becraft has been working at the bleeding edge of cancer research. Now, with solid early clinical results and a boatload of cash he’s hoping to bring his first innovative therapeutic...
7
21
126
We're thrilled to have been named one of Boston Business Journal's 2025 Best Places to Work — the BBJ’s exclusive ranking of the Massachusetts companies that have built outstanding work environments for their people! #BBJ #BPTW #BPTW2025 #BiotechNews #Biotech #mRNAResearch #mRNA
0
0
6
𝐀𝐒𝐂𝐎 𝟐𝟎𝟐𝟓: @StrandTx's Co-Founder & CEO @DrSynbio discusses the clinical data presentation for the company's IL-12, self-replicating mRNA cancer immunotherapy. #ASCO25 Full video: https://t.co/cYhIVaVJrt
2
3
16
Excited to share preliminary FIH Phase 1 data for STX-001: early signs of monotherapy activity and favorable safety in advanced solid tumors. Join us at ASCO: June 1, 9:00 AM-12:00 PM CDT, Abstract Number: 9556, Location: Hall A. Read our press release:
businesswire.com
Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigati...
0
1
9
Come by our abstract presentation tomorrow at #ASGCT2025 to learn about the groundbreaking data from the preclinical program for STX-003. Session Title: Targeted Gene and Cell Therapy for Cancer Date and Time: May 17, 8:15-8:30 am CT Abstract Number: 394 Location: Room 291-292
0
0
8
Come by our poster presentation today at #ASGCT2025 to learn about exciting ongoing work for our STX-005 program! Session Details: Date and Time: May 13, 6:00-7:30 pm CT Abstract #781 Location: Hall I1-I2 https://t.co/lT0XdMYlY3
annualmeeting.asgct.org
The unbiased source for reliable, scientific information, news, and breakthroughs in gene and cell therapy.
0
0
2
Over the weekend, Strands had the opportunity to volunteer at the #MassScienceFair Middle School State Fair! Shoutout to Gautam, Danish, Sanjana, Eloise, and Jaspreet for getting involved. #BeCurious #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies
0
0
5
Wishing all of the moms of Strand a happy Mother's Day! 💐 #MothersDay #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies
0
0
2
Strand had the wonderful opportunity to host some fantastic students from MIT's BioCEL and Ron Weiss's lab. It was fun to answer questions about life sciences careers, mRNA, biotech, and more! 🔬🧬 #BiotechNews #Biotech #mRNAResearch #mRNA #mRNATherapies
0
0
3
ASGCT Session Details: Session Type: Oral Session Title: Targeted Gene and Cell Therapy for Cancer Date and Time: May 17, 8:15-8:30 am CT Abstract Number: 394 Location: Room 291-292 Full abstract is available on the ASGCT Annual Meeting website.
annualmeeting.asgct.org
The unbiased source for reliable, scientific information, news, and breakthroughs in gene and cell therapy.
0
0
2